Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
CNS Pharmaceuticals, Inc. - Common Stock
(NQ:
CNSP
)
1.360
+0.150 (+12.40%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CNS Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
19
20
Next >
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Global Trial Targets Unmet Medical Need in Arresting GBM Brain Cancer
April 13, 2023
Via
Investor Brand Network
Study Explores Effects of MRI Scans During Cancer Treatment
April 12, 2023
Via
Investor Brand Network
Why iMedia Brands Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
April 12, 2023
Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) jumped 119.6% to $1.96 in pre-market trading. HeartCore forged an agreement with rYojbaba Inc for its tenth Go IPO consulting service win.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
April 12, 2023
Pre-market stock movers are a hot topic on Wednesday as we dive into all of the latest news affecting markets this morning.
Via
InvestorPlace
CNS Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
April 03, 2023
Via
ACCESSWIRE
Study Finds Repeated Head Trauma Increases Brain Cancer Risk
March 07, 2023
Via
Investor Brand Network
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Enrolls First Patient in Switzerland in Its Potentially Pivotal Global GBM Trial, Reports No Exposure to SVB Issues
April 11, 2023
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls Over 100 Patients in Potentially Pivotal Berubicin Study
April 10, 2023
Via
Investor Brand Network
Over 100 Patients Now Enrolled in CNS Pharmaceuticals’ (NASDAQ: CNSP) Potentially Pivotal Study Evaluating Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
April 10, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
April 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 07, 2023
Via
Benzinga
Why Levi Strauss Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 06, 2023
Gainers Liquid Media Group Ltd. (NASDAQ: YVR) jumped 88.1% to $0.2719.
Via
Benzinga
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Adds Italy to Growing Portfolio of Countries for Berubicin Study
April 06, 2023
Via
Investor Brand Network
Why CNS Pharmaceuticals Shares Are Trading Higher
April 06, 2023
CNS Pharmaceuticals Inc (NASDAQ: CNSP) shares are trading higher by 15.47% to $1.00 after the company announced it received approval from the Competent Authority and the central Ethics Committee in...
Via
Benzinga
CNS Pharmaceuticals Receives Approval from Competent Authority and Central Ethics Committee in Italy for Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
April 06, 2023
Via
ACCESSWIRE
Broad Cancer Analysis Finds Possibility for Tumor Reduction in Nearly All Cancers
April 05, 2023
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces FY 2022 Results, Corporate Update
April 03, 2023
Via
Investor Brand Network
AI Screens Brain Tumor Genes in Less Than Two Minutes
March 30, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Stocks That Hit 52-Week Lows On Monday
April 03, 2023
On Monday, 76 companies set new 52-week lows.
Via
Benzinga
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation in Upcoming Virtual Investor Event
March 29, 2023
Via
Investor Brand Network
Lighting Up Malignant Tissues Could Boost Precision of Surgical Removal
March 24, 2023
Via
Investor Brand Network
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Hits Key Milestone in Global GBM Clinical Trial with the Enrollment of First Patient in Spain
March 24, 2023
Via
Investor Brand Network
Normalizing Blood Vessels in Tumors Could Improve Brain Cancer Immunotherapy
March 20, 2023
Via
Investor Brand Network
Research Suggests Brain Cancers Could Be Detected Via Blood Tests
March 14, 2023
Via
Investor Brand Network
Topics
Death
Exposures
Death
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces It Has No Exposure to Silicon Valley Bank Issues
March 13, 2023
Via
Investor Brand Network
Study Documents Dangers of Halting Opioid Treatments for Chronic Pain
March 09, 2023
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls First Patient in Switzerland in Potentially Pivotal Berubicin Trial
March 09, 2023
Via
Investor Brand Network
Researchers Find Ways to Ease Cancer Treatment Outcome Prediction
February 23, 2023
Via
Investor Brand Network
New AI Tool Helps Personalize Breast Cancer Therapy
February 17, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 28, 2023
Gainers Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) shares jumped 153% to $3.24 after the company announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early...
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.